ANNE HOWLAND: Open Payments
NPI 1316900939 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 35 payments from 10 companies in 2025. Trend: 2023 $1,950 · 2024 $817 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $173 |
| Janssen Biotech, Inc. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Ardelyx, Inc. | 3 | $55 |
| Aimmune Therapeutics, Inc. | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: TREMFYA, CREON, RINVOQ, ENTYVIO, Wegovy, XIFAXAN, IBSRELA, ZENPEP.
Industry payments across VA — which companies pay providers there.
